Cannabis Sativa, Inc. (OTCQB:CBDS) announced the reorganization of its wholly owned subsidiary, KUSH, as a separate strategic business unit with former United States Senator Mike Gravel at the helm. KUSH will focus on the development and marketing of innovative new cannabis products for the recreational and medicinal markets including a proprietary lozenge called the “Kubby.”

Mike Gravel

Senator Gravel served as the U.S. Senator for Alaska from 1969 to 1981 and has been an outspoken critic of the failed “War on Drugs” since the Nixon era.

Steve Kubby, well-known medical marijuana pioneer and current Chairman of the Board for Cannabis Sativa, Inc., proclaimed: “Senator Gravel stood up to Nixon, stood up to the Pentagon, and now he is standing up to those in power who would keep the healthful benefits of cannabis from those who need them. He’s been a director of KUSH since its inception and brings invaluable perspective and connections to our group. He’s a true American hero and we’re excited to have him serving in this capacity.”

Senator Gravel stated: “I’m anxious to assist in bringing this important resource to a broader market in a serious and credible way.”

Senator Gravel served on the Finance, Interior, Environmental and Public Works committees, and chaired the Energy, Water Resources, Buildings and Grounds and Environmental Pollution subcommittees. Senator Gravel is best known for forcing an end to the military draft with a five-month filibuster and challenging the U.S. Government by releasing the Pentagon Papers. When the Nixon administration interrupted the New York Times, Washington Post and other newspapers from publishing with prior restraint injunctions, Senator Gravel stepped up to place the documents into the official Senate Record and facilitated their public distribution. Gravel has written several books, one of which, Citizen Power, devotes an entire chapter debunking the “War on Drugs.” A respected cannabis advocate, Senator Gravel has personally benefited from its medicinal use.

Comments

comments